SD Biosensor, Inc. is a healthcare company based in South Korea with a Risk Rating Score of 27.2, indicating a medium risk assessment. Specializing in in vitro diagnostics, the company focuses on providing rapid and accurate disease diagnosis to enhance the quality of life. SD Biosensor is at the forefront of researching and developing quick diagnostics, immunodiagnostics, molecular diagnostics, and blood glucose monitoring systems for self-testing. Their commitment to ESG initiatives sets them apart in the healthcare industry.